Protalix BioTherapeutics
PLX
#8943
Rank
NZ$0.36 B
Marketcap
NZ$4.56
Share price
1.18%
Change (1 day)
20.50%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): NZ$0.16

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.55. In 2022 the company made an earnings per share (EPS) of NZ-$0.53 an increase over its 2021 EPS that were of NZ-$1.10.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$0.16-129.78%
2022NZ-$0.53-51.61%
2021NZ-$1.10342.86%
2020NZ-$0.25-88.71%
2019NZ-$2.20-34.74%
2018NZ-$3.37-70.92%
2017NZ-$11.602153.35%
2016NZ-$0.51-146.77%
2015NZ$1.10-287.88%
2014NZ-$0.5910%
2013NZ-$0.53130.77%
2012NZ-$0.23-56.67%
2011NZ-$0.53-46.43%
2010NZ-$0.9936.59%
2009NZ-$0.7332.26%
2008NZ-$0.55-93.4%
2007NZ-$8.341298.53%
2006NZ-$0.60-96.59%
2005NZ-$17.5019.32%
2004NZ-$14.661552.65%
2003NZ-$0.89-0%
2002NZ-$0.89-50%
2001NZ-$1.77233.33%
2000NZ-$0.53-84.21%
1999NZ-$3.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.35 145.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$12.51 2,174.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.20-135.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.12 103.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel